Utama › Leukemia Limfoblastik Akut › Minnesota
Kajian klinikal Leukemia Limfoblastik Akut di Minnesota
14 kajian untuk Leukemia Limfoblastik Akut sedang mencari peserta di lokasi di Minnesota.
Bandar di Minnesota
Teks kajian rasmi (Bahasa Inggeris)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- dan 48 lagi
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
Mengambil pesertaFasa 1/2
Sehingga umur 22 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04726241Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospitals and Clinics of Minnesota, Minneapolis
Mengambil pesertaFasa 2
Umur 7 hingga 25 · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT05082519A Study of CTD402 in T-ALL/LBL Patients
- Mayo Clinic - Rochester, Rochester
Mengambil pesertaFasa 1/2
Umur 1 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07070219Allo HSCT Using RIC and PTCy for Hematological Diseases
- Masonic Cancer Center at University of Minnesota, Minneapolis
Mengambil pesertaFasa 2
Sehingga umur 75 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT05805605Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Masonic Cancer Center at University of Minnesota, Minneapolis
Mengambil pesertaFasa 2
Sehingga umur 60 · Semua jantina · Dikemas kini 25 Jun 2026 · NCT03314974TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Children's Hospital of Minnesota, Minneapolis
Mengambil pesertaFasa 1/2
Sehingga umur 1 · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05848687Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
- University of Minnesota/Masonic Cancer Center, Minneapolis
Mengambil pesertaKajian pemerhatian
Sehingga umur 25 · Semua jantina · Dikemas kini 8 Apr 2026 · NCT05014165MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
- University of Minnesota Masonic Cancer Center, Minneapolis
Mengambil pesertaFasa 2
Sehingga umur 60 · Semua jantina · Dikemas kini 6 Apr 2026 · NCT05735717Exploring the Effect of Calaspargase Pegol on the Coagulation System in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients: Pilot Study
- Mayo Clinic in Rochester, Rochester
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 22 · Semua jantina · Dikemas kini 13 Feb 2026 · NCT07071051Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
- Masonic Cancer Center, Minneapolis
Mengambil pesertaKajian pemerhatian
Umur 8 hingga 25 · Semua jantina · Dikemas kini 24 Nov 2025 · NCT05025774Auto Stem Cell Transplant for Lymphoma Patients
- Masonic Cancer Center, University of Minnesota, Minneapolis
Mengambil pesertaFasa 2
Sehingga umur 75 · Semua jantina · Dikemas kini 4 Nov 2025 · NCT03125642Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- University of Minnesota, Minneapolis
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital and Clinics of Minnesota, Minneapolis
Mengambil pesertaFasa 1
Umur 1 hingga 21 · Semua jantina · Dikemas kini 6 Dis 2024 · NCT05476770Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.